Fig. 3From: An evaluation of the real world use and clinical utility of the Cxbladder Monitor assay in the follow-up of patients previously treated for bladder cancerPatients completing the Cxbladder-Monitor test and flexible cystoscopy according to the protocol for (a) low-risk and (b) high-risk patients. Mean time to follow-up flexible cystoscopy is the time from the CxbM test. CxbM, Cxbladder-Monitor. *Patients proceeded to treatment for recurrent UCBack to article page